Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

BUY
$1.44 - $3.94 $5,104 - $13,967
3,545 Added 3.85%
95,621 $177,000
Q1 2022

May 13, 2022

SELL
$2.86 - $8.83 $3,889 - $12,008
-1,360 Reduced 1.46%
92,076 $328,000
Q4 2021

Feb 11, 2022

BUY
$4.94 - $8.94 $46,184 - $83,580
9,349 Added 11.12%
93,436 $804,000
Q3 2021

Nov 12, 2021

SELL
$6.05 - $10.81 $64,045 - $114,434
-10,586 Reduced 11.18%
84,087 $639,000
Q2 2021

Aug 13, 2021

SELL
$4.56 - $11.45 $289,067 - $725,838
-63,392 Reduced 40.11%
94,673 $628,000
Q1 2021

May 12, 2021

BUY
$11.65 - $37.0 $1.84 Million - $5.85 Million
158,065 New
158,065 $1.91 Million

Others Institutions Holding LHDX

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About Lucira Health, Inc.


  • Ticker LHDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 40,106,500
  • Market Cap $1.2M
  • Description
  • Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a paten...
More about LHDX
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.